Variants, Virulence, and Vaccines, Oh My!

Published: Sept. 7, 2021, 11 a.m.

b'Guest: Elitza S. Theel, Ph.D. (@ElliTheelPhD)\\nHost: Amit K. Ghosh, M.D. (@AmitGhosh006)\\nDr. Elitza Theel,\\xa0Professor of Laboratory Medicine and Pathology and Director of Infectious Diseases Serology Laboratory at Mayo Clinic\\u2019s Rochester Campus, discusses our immune response to vaccination and natural infection and outlines the different types of\\xa0antibody assays currently available. Dr. Theel\\xa0also discusses the concept of herd immunity in\\xa0the context of different circulating SARS-CoV-2 variants\\xa0and\\xa0the\\xa0increased need to get higher rates of vaccination in the community\\xa0as the\\xa0infectivity and transmissibility\\xa0of\\xa0circulating\\xa0SARS-CoV-2\\xa0variants\\xa0changes.\\xa0We also discuss the status of correlates of protective immunity against SARS-CoV-2 and the\\xa0need for booster vaccine doses\\xa0for immunocompromised individuals.\\xa0\\nAdditional resources:\\nInterim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html\\nConnect with the Mayo Clinic\\u2019s School of Continuous Professional Development\\xa0online at https://ce.mayo.edu/\\xa0or\\xa0on Twitter @MayoMedEd.'